Beam Therapeutics Inc.
BEAM
$23.91
$0.944.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.33% | -75.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.33% | -75.16% | |||
| Cost of Revenue | -5.73% | -84.49% | |||
| Gross Profit | 22.96% | 88.42% | |||
| SG&A Expenses | -3.87% | -2.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.47% | -2.57% | |||
| Operating Income | -0.73% | -19.24% | |||
| Income Before Tax | 6.39% | -20.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.39% | -20.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.39% | -20.94% | |||
| EBIT | -0.73% | -19.24% | |||
| EBITDA | -0.75% | -20.26% | |||
| EPS Basic | 19.26% | -13.86% | |||
| Normalized Basic EPS | 14.13% | -13.05% | |||
| EPS Diluted | 19.26% | -13.54% | |||
| Normalized Diluted EPS | 14.13% | -13.05% | |||
| Average Basic Shares Outstanding | 15.94% | 6.22% | |||
| Average Diluted Shares Outstanding | 15.94% | 6.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||